Atara Biotherapeutics Inc (ATRA) — Working Capital to Net Assets Ratio
Atara Biotherapeutics Inc (ATRA) has a Working Capital to Net Assets ratio of -1.0% as of September 2025. Working capital of $375.00K (current assets of $18.43 Million minus current liabilities of $18.06 Million) is measured against net assets of $-36.63 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Atara Biotherapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Atara Biotherapeutics Inc Working Capital to Net Assets (2012–2024)
This chart shows how Atara Biotherapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at -1.0%, reflecting working capital of $375.00K against net assets of $-36.63 Million USD. Check Atara Biotherapeutics Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Atara Biotherapeutics Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Atara Biotherapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Atara Biotherapeutics Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 71.6% | $-69.68 Million | $-97.28 Million | $64.89 Million | $134.57 Million | ▲ +31.0 pp |
| 2023 | 40.7% | $-40.36 Million | $-99.23 Million | $101.87 Million | $142.23 Million | ▼ -130.0 pp |
| 2022 | 170.7% | $216.16 Million | $126.64 Million | $295.08 Million | $78.92 Million | ▲ +71.0 pp |
| 2021 | 99.7% | $278.83 Million | $279.61 Million | $384.62 Million | $105.79 Million | ▲ +4.5 pp |
| 2020 | 95.2% | $440.37 Million | $462.34 Million | $523.27 Million | $82.90 Million | ▲ +14.0 pp |
| 2019 | 81.2% | $236.25 Million | $290.78 Million | $272.99 Million | $36.74 Million | ▼ -1.8 pp |
| 2018 | 83.1% | $281.51 Million | $338.86 Million | $321.49 Million | $39.98 Million | ▲ +1.8 pp |
| 2017 | 81.3% | $144.54 Million | $177.86 Million | $172.19 Million | $27.65 Million | ▼ -17.6 pp |
| 2016 | 98.9% | $250.88 Million | $253.74 Million | $260.55 Million | $9.68 Million | ▼ -1.1 pp |
| 2015 | 99.9% | $314.89 Million | $315.10 Million | $324.60 Million | $9.71 Million | ▼ -0.2 pp |
| 2014 | 100.1% | $103.30 Million | $103.18 Million | $106.03 Million | $2.72 Million | ▲ +556.5 pp |
| 2013 | -456.4% | $50.28 Million | $-11.02 Million | $51.81 Million | $1.52 Million | ▼ -377.5 pp |
| 2012 | -78.9% | $2.94 Million | $-3.73 Million | $4.24 Million | $1.30 Million | — |